Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients

Blood

Volumn 90, Issue 8, 1997, Pages 2939-2951

  Glaspy, J A ^a   Shpall, E J ^b   LeMaistre, C F ^b   Briddell, R A ^b   Menchaca, D M ^b   Turner, S A ^b   Lill, M ^b   Chap, L ^b   Jones, R ^b   Wiers, M D ^b   Sheridan, W P ^b   McNiece, I K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ADULT; ALLERGY; APHERESIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RASH; STEM CELL; URTICARIA;

EID: 0030761883     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.2939     Document Type: Article

References (45)

1. Gianni AM, Bregni M, Stern AC, Siena S, Tarella C, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2:580, 1989
2. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
3. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353, 1996
4. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Stayagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE: Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
5. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA: Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
6. Huss R, Hong DS, Beckham C, Kimball L, Myerson DH, Storb R, Deeg HJ: Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells. Exp Hematol 23:33, 1995
7. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77:2316, 1991
8. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226, 1991
9. Funk PE, Stephan RP, Witte PL: Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow. Blood 86:2661, 1995
10. Fleischman RA, Simpson F, Gallardo T, Jin XL, Perkins S: Isolation of endothelial-like stromal cells that express Kit ligand and support in vitro hematopoiesis. Exp Hematol 23:1407, 1995
11. Rameshwar P, Gascon P: Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86:482, 1995
12. Ulich TR, del Castillo JC, McNiece IK, Yi ES, Alzona CP, Yin SM, Zsebo KM: Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo. Blood 78:1954, 1991
13. Molineux G, Migdalska A, Szmitkowski M, Zsebo KM, Dexter TM: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
14. Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo KM, Weite K: Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 80:1199, 1992
15. Ulich TR, Yi ES, Yin SM, del Castillo JC, McNiece IK, Yung YP, Zsebo KM: Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents. Int Rev Exp Pathol 34:215, 1993
16. + colony-forming cell types in blood and marrow of baboons. Blood 80:920, 1992
17. Andrews RG, Bensinger WI, Knitter GH, Bartelmez SH, Longin K, Bernstein ID, Appelbaum FR, Zsebo KM: The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715, 1992
18. McNiece IK, Briddell RA, Hartley CA, Smith KA, Andrews RG: Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cells 11:36, 1993 (suppl 2)
19. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
20. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson DH, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800, 1994
21. de Revel T, Appelbaum FR, Storb R, Schuening FG, Nash R, Deeg HJ, McNiece IK, Andrews RG, Graham TC: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
22. Drize N, Chertkov J, Zander A: Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Exp Hematol 23:1180, 1995
23. Yan XQ, Hartley CA, McElroy P, Chang A, McCrea C, McNiece IK: Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice. Blood 85:2303, 1995
24. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85:15, 1995
25. Crawford J, Lau D, Erwin R, Rich W, McGuire B, Meyers F: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients (pts) with advanced non-small cell lung carcinoma (NSCLC). Proc Am Soc Clin Oncol 12:135, 1993 (abstr)
26. Demetri GD, Costa JJ, Hayes DF, Sledge GJ, Galli SJ, Hoffman R, Merica EA, Rich W, Harkins B, McGuire B, Gordon MS: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced breast carcinoma pre-and post-chemotherapy (chemo) with cyclophosphamide (C) and doxorubicin (A). Proc Am Soc Clin Oncol 12:142. 1993 (abstr)
27. Orazi A, Gordon MS, John K, Sledge GJ, Neiman RS, Hoffman R: In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsies. Am J Clin Pathol 103:177, 1995
28. Kurtzberg J, Meyers F, McGuire B, Crawford J: Mobilization of peripheral blood progenitor cells in patients given recombinant methionyl human stem cell factor. Proc Annu Meet Am Assoc Cancer Res 34:A1257, 1993 (abstr)
29. Grichnik JM, Crawford J, Jimenez F, Kurtzberg J, Buchanan M, Blackwell S, Clark RE, Hitchcock MG: Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol 33:577, 1995
30. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681, 1996
31. Brandt JE, Baird N, Lu L, Srour EF, Hoffman R: Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 82:1017, 1988
32. Bradley TR, Hodgson GS, Rosendaal M: The effect of oxygen tension on hemopoietic and fibroblast cell proliferation in vitro. J Cell Physiol 94:517, 1978
33. Moskowitz C, Stiff P, Gordon MS, Gabrilove JL, Bayer R, Broun R, Nichols C, Ho AD, Wyres M, Nimer SD, McNiece IK: The influence of extensive prior chemotherapy on the mobilization of peripheral blood progenitor cells (PBPC) using stem cell factor (rhSCF) and filgrastim (r-metHuG-CSF) and on hematologic recovery post cyclophosphamide, BCNU, and VP-16 (CBV) in patients (pts) with relapsed non-Hodgkin's lymphoma (NHL): An interim analysis. Blood 84:107a, 1994 (suppl 1, abstr)
34. Begley CG, Basser R, Mansfield R, Maher D, To LB, Juttner CA, Fox RM, Cebon J, Grigg AP, Szer J, McGrath KM, Thomson B, Sheridan WP, Menchaca DM, Collins J, Russell I, Green MD: Randomized prospective study demonstrating a prolonged effect of SCF with G-CSF (filgrastim) on PBPC in untreated patients: Early results. Blood 84:25a, 1994 (suppl 1, abstr)
35. Tricot G, Jagannath S, Desikan KR, Siegel D, Munshi N, Olson E, Wyres M, Parker W, Barlogie B: Superior mobilization of peripheral blood progenitor cells (PBPC) with r-metHuSCF (SCF) and r-metHuG-CSF (filgrastim) in heavily pretreated multiple myeloma (MM) patients. Blood 88:388a, 1996 (abstr, suppl 1)
36. Lane TA, Law P, Maruyama M, Young D, Mullen M; Terstappen L, Corringham RET, Ho AD: Mobilization of peripheral blood stem cells in normal donors by GCSF and GMCSF: Potential role in allogeneic marrow transplantation. Proc Am Soc Clin Oncol 14:74, 1995 (abstr)
37. Rosenfeld CS, Bolwell BJ, LeFever A, Taylor R, List A, Fay JW, Collins R, Andrews F, Pallansch P, Schuster MW, Resta D, Levitt D, Nemunaitis J: Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. Bone Marrow Transplant 17:179, 1996
38. Abboud CN, Reykdal S, Liesveld JL, Belanger TJ, Haug JS, Rosell KE, Kempski MC, Flesher WR, DiPersio JF: Prospective randomized trial (NCI/T92-0010), comparing the efficacy of hematopoietic growth factors, for mobilizing peripheral blood stem cells (PBSC) in autologous bone marrow transplantation: II. Progenitor mobilization kinetics. Blood 86:1839, 1995 (abstr)
39. Demirer T, Buckner CD, Bensinger WI: Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106, 1996
40. Weaver A, Ryder D, Crowther D, Dexter TM, Testa NG: Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood 88:3323, 1996
41. Weaver CH, Hazelton B, Palmer PA, Li W, Birch R, Alberico T, West WH, Schwartzberg LS: A randomized dose finding study of filgrastim for mobilization of peripheral blood progenitor cells (PBPCs). Proc Am Soc Clin Oncol 15:341, 1996 (abstr)
42. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:558, 1995
43. Bensinger WI, Appelbaum FR, Rowley SD, Storb R, Sanders JE, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift RA, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden PL, Witherspoon RP, Buckner CD: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995
44. Dreger P, Kloss M, Petersen B, Haferlach T, Loffler H, Loeffler M, Schmitz N: Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cells but not of bone marrow grafts. Blood 86:3970, 1995
45. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437, 1995